Spier CM - Search Results

1

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.

Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani BN, et al. Miller TP, et al. Among authors: spier cm. Blood. 1994 Mar 15;83(6):1460-6. Blood. 1994. PMID: 8123837 Free article. Clinical Trial.

2

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, Delabie J, Rosenwald A, Staudt LM, Grogan TM. Rimsza LM, et al. Among authors: spier cm. Blood. 2004 Jun 1;103(11):4251-8. doi: 10.1182/blood-2003-07-2365. Epub 2004 Feb 19. Blood. 2004. PMID: 14976040 Free article.

3

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.

Braziel RM, Arber DA, Slovak ML, Gulley ML, Spier C, Kjeldsberg C, Unger J, Miller TP, Tubbs R, Leith C, Fisher RI, Grogan TM. Braziel RM, et al. Blood. 2001 Jun 15;97(12):3713-20. doi: 10.1182/blood.v97.12.3713. Blood. 2001. PMID: 11389007 Free article.

4

P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.

Grogan TM, Spier CM, Salmon SE, Matzner M, Rybski J, Weinstein RS, Scheper RJ, Dalton WS. Grogan TM, et al. Among authors: spier cm. Blood. 1993 Jan 15;81(2):490-5. Blood. 1993. PMID: 8093668 Free article.

5

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.

Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, LeBlanc M, Carlin S, Chase E, Fisher RI. Miller TP, et al. Among authors: spier cm. N Engl J Med. 1998 Jul 2;339(1):21-6. doi: 10.1056/NEJM199807023390104. N Engl J Med. 1998. PMID: 9647875 Free article. Clinical Trial.

6

Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement.

Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Kern WF, et al. Among authors: spier cm. Blood. 1992 May 1;79(9):2432-7. Blood. 1992. PMID: 1373974 Free article.

7

Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsets.

Leith CP, Spier CM, Grogan TM, Gonzales G, Rangel CS, Rybski JA, Matzner M, Miller TP. Leith CP, et al. Among authors: spier cm. J Clin Oncol. 1992 Aug;10(8):1259-65. doi: 10.1200/JCO.1992.10.8.1259. J Clin Oncol. 1992. PMID: 1634915

8

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

Lippman SM, Spier CM, Miller TP, Slymen DJ, Rybski JA, Grogan TM. Lippman SM, et al. Among authors: spier cm. Mod Pathol. 1990 May;3(3):361-7. Mod Pathol. 1990. PMID: 2194216

9

Myelomonocytic antigen positive multiple myeloma.

Grogan TM, Durie BG, Spier CM, Richter L, Vela E. Grogan TM, et al. Among authors: spier cm. Blood. 1989 Feb 15;73(3):763-9. Blood. 1989. PMID: 2644987 Free article.

10

Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival.

Spier CM, Lippman SM, Miller TP, Grogan TM. Spier CM, et al. Cancer. 1988 Feb 1;61(3):517-24. doi: 10.1002/1097-0142(19880201)61:3<517::aid-cncr2820610317>3.0.co;2-1. Cancer. 1988. PMID: 3257404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters